SCHOTT AG

SCHOTT AG, founded in 1884 and headquartered in Mainz, Germany, is a global leader in specialty glass and glass-ceramics, reporting €2.83 billion in revenue for fiscal year 2025 and employing 17,392 people worldwide.

Business Overview

SCHOTT operates through four primary segments: optical glass, pharmaceutical packaging, glass-ceramics, and semiconductor/aerospace substrates. The company's foundation-owned structure allows it to prioritize long-term R&D, resulting in proprietary technologies such as ZERODUR® zero-expansion glass-ceramics used in the world's largest telescopes and advanced lithography systems. Its pharmaceutical division, listed as SCHOTT Pharma (Frankfurt: 1SXP), is a major supplier of borosilicate vials and syringes, producing over 13 billion containers annually for the global healthcare industry.

Key Strengths

SCHOTT's key strengths include its foundation ownership, which insulates the company from short-term market pressures and enables sustained investment in high-tech glass R&D. The company holds a dominant position in zero-expansion glass-ceramics and ultra-pure optical glass, with production capacity among the largest globally for these specialized materials. Its diversified portfolio across pharmaceuticals, optics, semiconductors, and industrial ceramics reduces reliance on any single end-market. A global footprint spanning more than 30 countries provides robust supply chain resilience and customer proximity.

Challenges & Outlook

SCHOTT faces challenges from intense competition in display and optical glass from Asian manufacturers, as well as potential regulatory shifts in pharmaceutical packaging. The company's niche focus limits its absolute scale compared to mass-market glass producers. However, growing demand for advanced semiconductor substrates, high-end optical components, and pharmaceutical containment solutions positions SCHOTT for steady growth. VerityRank assigns SCHOTT a VerityRank Score of 89/100.